1356003-72-9Relevant academic research and scientific papers
PEPTIDYLARGININE DEIMINASES (PAD) INHIBITORS
-
Page/Page column 71, (2014/12/12)
The present invention relates to compounds of the formula (I): as inhibitors of peptidylarginine deiminases (PADs). It also concerns their use in therapy, particularly in the prophylaxis or treatment of neural injury, and other conditions including cancer, multiple sclerosis, glaucoma, arthritis, rheumatoid arthritis lupus, Alzheimer's disease, and ulcerative colitis.
Thiohydantoins: Selective N- and S-functionalization for Liebeskind-Srogl reaction study
Gosling, Sandrine,Rollin, Patrick,Tatibouet, Arnaud
, p. 3649 - 3660 (2011/12/21)
Thiohydantoins formed by the Schlack-Kumpf protocol were selectively functionalized at the nitrogen, sulfur, or carbon atom to test the Liebeskind-Srogl reaction possibilities. Georg Thieme Verlag Stuttgart. New York.
